In typography, kerning is the process of adjusting the space between two specific characters. Most of us never give it a ...

Fast Startup has been a part of the operating system since Windows 8, and while it helped at the time, the feature no longer ...

Pune: A screening test for selection of students for pre-examination training for the Maharashtra Public Service Commission’s ...

Ghost announced Monday its official emergence from stealth and an $11 billion seed round led by Andreessen Horowitz.

An unprecedented digital blackout transformed the start of the Grand Prix of Bahrain (disputed in Malaysia) in one of the most chaotic episodes in the recent history of Formula 1.

When he's not writing, you'll probably find him hitting the gym, trying to ace a new hobby, reading his textbooks, or traveling. You can reach him at me@arolwright.com. Dual-booting Windows and Linux ...

Carfreitag brings a special kind of madness to the Nürburgring Nordschleife as Touristenfahrten fills with busy traffic, fails, bold driving and unpredictable action. With so much happening around the ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. When ...

Washington — The Senate on Tuesday failed to advance a sweeping cryptocurrency bill known as the Clarity Act, amid opposition from Democrats and a handful of Republicans. In a 49 to 50 vote, the ...

Microsoft has confirmed that USB audio devices may fail on some Windows systems after installing the KB5124008 and KB5124012 September 2026 security updates. This known issue affects only devices ...

Elon Musk’s tunnel construction startup, The Boring Company, has ‌raised $3 billion in a new funding round. The company is now valued at $23 billion. According to Reuters, the funding round was led by ...

Novartis AG suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study, raising questions about the drugmaker’s growth prospects.